SciELO - Scientific Electronic Library Online

 
vol.8 número1Monitoreo continuo del segmento ST a través del electrograma intracardíaco por un dispositivo cardíaco implantable índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Insuficiencia cardíaca

versión On-line ISSN 1852-3862

Resumen

LANZIERI¹, Pedro Gemal et al. Alcoholic cardiomyopathy aggravated by cancer chemotherapy. Insuf. card. [online]. 2013, vol.8, n.1, pp.41-45. ISSN 1852-3862.

Background. Cardiomyopathy (CMP) and heart failure (HF) are severe clinical conditions, both with high morbidity and mortality rates. The longer life expectancy of patients with cancer (CA) increases the risks of developing CMP and HF. Objectives. Report cases of alcoholic CMP aggravated by chemotherapy (CT) for Hodgkin's lymphoma. Case Report.Female, 50 years old, black with CMP alcoholic, was diagnosed with Hodgkin's lymphoma after screening of cervical adenomegaly. After eight months of CT with doxorubicin (530 mg/m2), bleomycin and vinblastine, showed worsening of functional class and frequent decompensation. There was a significant decrease in left ventricular ejection fraction, successive hospitalizations for decompensation and evolution to New York Heart Association (NYHA) functional class IV and stage D of the American Heart Association/American College of Cardiology. Conclusion. Theanthracyclinecardiotoxicityoccurs morefrequently inpatients with predisposing factors.Anypreviousinjuryto the myocardiumisrisk toCMP due to CT.In this case it is probable that the alcoholic CMP had clinical course aggravated by CT.

Palabras clave : Alcoholic cardiomyopathy; Alcoholism; Heart Failure; Chemotherapy; Doxorubicin; Hodgkin's lymphoma.

        · resumen en Español | Portugués     · texto en Portugués     · Portugués ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons